Olson, Robert http://orcid.org/0000-0003-4532-6197
Schlijper, Roel
Chng, Nick
Matthews, Quinn
Arimare, Marco
Mathews, Lindsay
Hsu, Fred
Berrang, Tanya
Louie, Alexander
Mou, Benjamin
Valev, Boris
Laba, Joanna
Palma, David
Schellenberg, Devin
Lefresne, Shilo
Funding for this research was provided by:
BC Cancer Foundation
Article History
Received: 21 June 2019
Accepted: 14 October 2019
First Online: 28 October 2019
Ethics approval and consent to participate
: The study has been approved by the University of British Columbia Research Ethics Board in compliance with the Helsinki Declaration. All included patients have to give their written consent before entering the study. Informed consent will be obtained at individual participating institutions by study investigators or clinical trials staff members. As of publication date, the participating sites include all six BC Cancer sites (Abbotsford, Kelowna, Prince George, Surrey, Vancouver, Victoria) and the London Health Sciences Centre.
: Not applicable.
: Dr. Olson and Dr. Schellenberg have received grant funding from Varian Medical Systems, unrelated to this trial.